Siglec-8. A novel eosinophil-specific member of the immunoglobulin superfamily
about
Mechanisms of Siglec-F-induced eosinophil apoptosis: a role for caspases but not for SHP-1, Src kinases, NADPH oxidase or reactive oxygenChronic OVA allergen challenged Siglec-F deficient mice have increased mucus, remodeling, and epithelial Siglec-F ligands which are up-regulated by IL-4 and IL-13Identification, characterization and leucocyte expression of Siglec-10, a novel human sialic acid-binding receptorCharacterization of expression of glycan ligands for Siglec-F in normal mouse lungsIL-33 enhances Siglec-8 mediated apoptosis of human eosinophilsDevelopmental, malignancy-related, and cross-species analysis of eosinophil, mast cell, and basophil siglec-8 expressionAnti-Siglec-F antibody inhibits oral egg allergen induced intestinal eosinophilic inflammation in a mouse modelAnti-Siglec-F antibody reduces allergen-induced eosinophilic inflammation and airway remodelingSiglec-F antibody administration to mice selectively reduces blood and tissue eosinophilsDefining the in vivo function of Siglec-F, a CD33-related Siglec expressed on mouse eosinophilsSiglecs in the immune systemAntigen delivery to macrophages using liposomal nanoparticles targeting sialoadhesin/CD169Mouse Siglec-F and human Siglec-8 are functionally convergent paralogs that are selectively expressed on eosinophils and recognize 6'-sulfo-sialyl Lewis X as a preferred glycan ligandMechanism of Siglec-8-mediated cell death in IL-5-activated eosinophils: role for reactive oxygen species-enhanced MEK/ERK activationGlycan array screening reveals a candidate ligand for Siglec-8mSiglec-E, a novel mouse CD33-related siglec (sialic acid-binding immunoglobulin-like lectin) that recruits Src homology 2 (SH2)-domain-containing protein tyrosine phosphatases SHP-1 and SHP-2Multivalent Interactions of Human Primary Amine Oxidase with the V and C22 Domains of Sialic Acid-Binding Immunoglobulin-Like Lectin-9 Regulate Its Binding and Amine Oxidase ActivityCloning and characterization of Siglec-10, a novel sialic acid binding member of the Ig superfamily, from human dendritic cells.Siglec-9, a novel sialic acid binding member of the immunoglobulin superfamily expressed broadly on human blood leukocytes.A comparative study of the asparagine-linked oligosaccharides on siglec-5, siglec-7 and siglec-8, expressed in a CHO cell line, and their contribution to ligand recognition.Production of monoclonal antibodies reactive with ovine eosinophilsIdentification and characterization of S2V, a novel putative siglec that contains two V set Ig-like domains and recruits protein-tyrosine phosphatases SHPs.Controlling allergic inflammation by signaling regulation of eosinophils.New functions for the sialic acid-binding adhesion molecule CD22, a member of the growing family of Siglecs.Siglec-mediated regulation of immune cell function in disease.Tyrosine Kinase Inhibitors and Therapeutic Antibodies in Advanced Eosinophilic Disorders and Systemic Mastocytosis.Intracellular signal transduction in eosinophils and its clinical significance.CD33/Siglec-3 binding specificity, expression pattern, and consequences of gene deletion in miceAdditive anti-allergic effects of anti-interleukin-33 and anti-Siglec-F treatments in a murine model of allergic asthma.Group B streptococcal capsular sialic acids interact with siglecs (immunoglobulin-like lectins) on human leukocytesBiomarkers of eosinophil involvement in allergic and eosinophilic diseases: review of phenotypic and serum markers including a novel assay to quantify levels of soluble Siglec-8Isolation of human eosinophilsSiglec-8 as a drugable target to treat eosinophil and mast cell-associated conditions.Differences in the constitutive and SIV infection induced expression of Siglecs by hematopoietic cells from non-human primates."Siglec"ting the allergic response for therapeutic targeting.Immunologic and inflammatory mechanisms that drive asthma progression to remodelingStructural basis for sulfation-dependent self-glycan recognition by the human immune-inhibitory receptor Siglec-8Origin, regulation and physiological function of intestinal oeosinophils.Siglec-8 on human eosinophils and mast cells, and Siglec-F on murine eosinophils, are functionally related inhibitory receptors.Basic and clinical immunology of Siglecs
P2860
Q21132992-24CEE5E5-E8E3-46C2-9700-8DDDCA5D0C0EQ21284418-6CF4C36A-34A6-42FD-9E05-31F864179492Q24532754-A4AEC717-9FA9-43C1-8EF5-AA02497B2004Q24608549-1EC479C9-13E3-48B0-8EB7-6C0057DE70C5Q24631401-34590746-DE2D-409F-BF66-12EEBA5E9431Q24634555-6BCD691B-C4D6-41F4-A9B3-F84868F9EC70Q24642063-F15E81C0-C847-4723-9762-07C65F745F29Q24645925-D34D4540-A032-4C59-936B-D1F335DDB72EQ24651513-4EC7A2F6-0D23-461E-BE34-5B93B7868A28Q24678441-DD56CEDF-3540-479A-99B8-29F0246CE4C0Q24682458-23A6EFD7-2251-4D8D-8C11-1F3FDBE282AFQ27301034-51A47B68-C545-4DD9-B739-9290B80D6029Q28257968-612D0A36-3A68-4C20-9D2D-5675FEBE57E7Q28290873-F25D7B3E-C80E-4BB9-90DB-672BE8BC13F4Q28295084-CAA79DB2-9DC1-4AFA-82E7-599B8117DACBQ28347604-8B281FDF-A906-4251-8A90-2A59525EEB5DQ28554453-86F43B5D-BEF0-42CF-BDC7-8338905D752EQ30669536-F8127DE9-BA92-4BB4-AB5F-DA61BEBA057FQ30868758-3CAC2575-A507-48F7-9DE9-631E30200348Q32081092-FAE783EF-ADDE-41E2-A918-067693665EE0Q33300477-FA10BEE9-DFF2-412C-89C0-CDA2450BF543Q33944757-A5CE30AA-2128-4798-A2FF-9B3597395228Q34184626-5AE8A896-D7EC-4E1D-9B21-2A992021234DQ34184901-B65D61C2-CD17-474D-B262-65E45F54EAA1Q34314957-A78F8DC3-EC89-415D-A4A4-08D11043CB1DQ34495630-C1033232-C99B-4E09-BD89-616E0FE4B71BQ34687385-90D128FF-FFCA-4C3E-BD00-033EB93F20A0Q35019914-1E4A8EA7-E25A-466A-BBBB-25DC9349BB53Q35631650-04AECD56-01F9-43E3-88F3-1A794456A62DQ35634692-20C32B41-7402-4D43-BA98-FBE9B3230F2FQ36139731-F96C4B6E-85F6-4534-8B92-387C9D90E146Q36169563-41A1BD38-61F1-443B-95F8-C635B9708B55Q36655884-DAC345D6-62E4-43A4-98A1-DCCA78A48DA4Q36691835-C32EE7EF-B6B1-40A2-A802-AC5BCABFA439Q36843245-FA2E3EBB-B4F7-4479-BABA-6A14EF5DF0BAQ37105324-F2BA0B33-CB85-48EA-88CA-02AB9EB036CEQ37126813-FE6E8766-FD3E-49B2-8E65-DFDC29107606Q37168735-0B111BF5-9CF3-4EBD-8638-5791FE6A88F5Q37343465-9DE1DA8F-E89E-4156-BC83-2845838FA99FQ37348437-B6F6B098-3DD1-4622-8140-04DB3BD18DFD
P2860
Siglec-8. A novel eosinophil-specific member of the immunoglobulin superfamily
description
2000 nî lūn-bûn
@nan
2000 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
Siglec-8. A novel eosinophil-specific member of the immunoglobulin superfamily
@ast
Siglec-8. A novel eosinophil-specific member of the immunoglobulin superfamily
@en
Siglec-8. A novel eosinophil-specific member of the immunoglobulin superfamily
@en-gb
Siglec-8. A novel eosinophil-specific member of the immunoglobulin superfamily
@nl
type
label
Siglec-8. A novel eosinophil-specific member of the immunoglobulin superfamily
@ast
Siglec-8. A novel eosinophil-specific member of the immunoglobulin superfamily
@en
Siglec-8. A novel eosinophil-specific member of the immunoglobulin superfamily
@en-gb
Siglec-8. A novel eosinophil-specific member of the immunoglobulin superfamily
@nl
prefLabel
Siglec-8. A novel eosinophil-specific member of the immunoglobulin superfamily
@ast
Siglec-8. A novel eosinophil-specific member of the immunoglobulin superfamily
@en
Siglec-8. A novel eosinophil-specific member of the immunoglobulin superfamily
@en-gb
Siglec-8. A novel eosinophil-specific member of the immunoglobulin superfamily
@nl
P2093
P356
P1476
Siglec-8. A novel eosinophil-specific member of the immunoglobulin superfamily
@en
P2093
A L Cornish
K C Carter
P R Crocker
P356
10.1074/JBC.275.2.861
P407
P577
2000-01-14T00:00:00Z